Skip to main content
SpringerLink
Log in

Dihydroergotamine vs triptans and NSAIDs in pregnancy

  • Clinical study
  • Published:
Reactions Weekly Aims and scope

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

REFERENCE

  1. Bérard A, Sheehy O, Kori SH.Dihydroergotamine (DHE) use during gestation and the risk of adverse pregnancy outcomes. 53rd Annual Scientific Meeting of the American Headache Society: abstr. P84, 2 Jun 2011. Available from: URL: https://www.americanheadachesociety.org

Download references

Rights and permissions

Reprints and permissions

About this article

Cite this article

Dihydroergotamine vs triptans and NSAIDs in pregnancy. React. Wkly. 1359, 4 (2011). https://doi.org/10.2165/00128415-201113590-00009

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.2165/00128415-201113590-00009

Keywords

Search

Navigation